LeMaitre Vascular

+22.87%

Live  

LeMaitre Vascular is a global medical device company that specializes in developing and providing innovative devices and solutions for the treatment of peripheral vascular disease. The company was founded in 1983 and is headquartered in Burlington, Massachusetts.
Products and services
The company's products and services are focused on five main categories:
1. Open vascular surgery: This includes a range of surgical instruments and accessories for a variety of open surgical procedures, including aortic repair, peripheral bypass, and carotid endarterectomy.
2. Endovascular surgery: LeMaitre Vascular offers a range of endovascular devices, including stent grafts, balloon catheters, and vascular access products.
3. Compression therapy: The company provides a variety of products for venous and lymphatic disorders, including compression garments, pumps, and bandages.
4. Dialysis: LeMaitre Vascular offers a range of products for hemodialysis access, including catheters, grafts, and accessories.
5. Cardiac surgery: The company also offers a range of devices and solutions for cardiac surgery, including cannulae, tubing sets, and heart valve repair devices.
Global presence
LeMaitre Vascular has a presence in over 80 countries worldwide, with subsidiaries and distribution partners in Europe, Latin America, Asia-Pacific, and the Middle East. The company's products are sold in over 50 countries and are used by over 13,000 surgeons.
Research and development
The company is committed to investing in research and development to bring new and innovative products to the market. LeMaitre Vascular has a team of over 100 scientists, engineers, and product managers dedicated to developing new technologies and improving existing products.
Partnerships and collaborations
LeMaitre Vascular works closely with physicians and medical professionals to understand their needs and develop products that meet their specific requirements. The company also partners with other medical device companies and institutions to expand its product portfolio and offer comprehensive solutions for vascular disease treatment.
Financial information
LeMaitre Vascular is a publicly traded company on the Nasdaq stock exchange (Ticker Symbol: LMAT). As of 2021, the company's annual revenue was $144.74 million.

MS4gV29ybG QtcmVub3du ZWQgcmVwdX RhdGlvbjog TGVNYWl0cm UgVmFzY3Vs YXIgaXMgYS BsZWFkaW5n IGdsb2JhbC Bwcm92aWRl ciBvZiBtZW RpY2FsIGRl dmljZXMgZm 9yIHRoZSB0 cmVhdG1lbn Qgb2YgcGVy aXBoZXJhbC B2YXNjdWxh ciBkaXNlYX NlLiBUaGUg Y29tcGFueS BoYXMgYSBs b25nLXN0YW 5kaW5nIHJl cHV0YXRpb2 4gZm9yIGhp Z2gtcXVhbG l0eSBwcm9k dWN0cyBhbm QgaW5ub3Zh dGlvbiBpbi B0aGUgbWVk aWNhbCBkZX ZpY2UgaW5k dXN0cnkuPG JyPjIuIEZv Y3VzIG9uIH Zhc2N1bGFy IHN1cmdlcn k6IExlTWFp dHJlIFZhc2 N1bGFyIGV4 Y2x1c2l2ZW x5IGZvY3Vz ZXMgb24gcH JvZHVjdHMg YW5kIHNvbH V0aW9ucyBm b3IgdmFzY3 VsYXIgc3Vy Z2VyeSwgbW FraW5nIHRo ZW0gZXhwZX J0cyBpbiB0 aGlzIGZpZW xkLjxicj4z LiBXaWRlIH JhbmdlIG9m IHByb2R1Y3 RzOiBUaGUg Y29tcGFueS BvZmZlcnMg YSBjb21wcm VoZW5zaXZl IHBvcnRmb2 xpbyBvZiBv dmVyIDUwMC B2YXNjdWxh ciBkZXZpY2 VzLCBpbmNs dWRpbmcgZG V2aWNlcyBm b3Igb3Blbi BhbmQgZW5k b3Zhc2N1bG FyIHByb2Nl ZHVyZXMsIG FzIHdlbGwg YXMgZm9yIH RoZSB0cmVh dG1lbnQgb2 YgdmVub3Vz IGRpc2Vhc2 UuPGJyPjQu IE9uZ29pbm cgcHJvZHVj dCBpbm5vdm F0aW9uOiBM ZU1haXRyZS BWYXNjdWxh ciBpbnZlc3 RzIGhlYXZp bHkgaW4gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 IHRvIGNvbn RpbnVvdXNs eSBpbXByb3 ZlIGFuZCBl eHBhbmQgdG hlaXIgcHJv ZHVjdCBvZm ZlcmluZ3Mu IFRoZXkgaG F2ZSBhIGRl ZGljYXRlZC B0ZWFtIG9m IGVuZ2luZW VycyBhbmQg c2NpZW50aX N0cyBmb2N1 c2VkIG9uIG RldmVsb3Bp bmcgbmV3IG FuZCBpbm5v dmF0aXZlIH NvbHV0aW9u cyBmb3Igdm FzY3VsYXIg c3VyZ2VyeS 48YnI+NS4g U3Ryb25nIH ByZXNlbmNl IGluIGdsb2 JhbCBtYXJr ZXRzOiBUaG UgY29tcGFu eSBoYXMgYS BzdHJvbmcg aW50ZXJuYX Rpb25hbCBw cmVzZW5jZS B3aXRoIG9w ZXJhdGlvbn MgaW4gRXVy b3BlLCBBc2 lhLCBhbmQg TGF0aW4gQW 1lcmljYSwg YWxsb3dpbm cgdGhlbSB0 byByZWFjaC BhIHdpZGUg cmFuZ2Ugb2 YgY3VzdG9t ZXJzIGdsb2 JhbGx5Ljxi cj42LiBDb2 1taXRtZW50 IHRvIHBhdG llbnQgc2Fm ZXR5OiBMZU 1haXRyZSBW YXNjdWxhci BpcyBjb21t aXR0ZWQgdG 8gcGF0aWVu dCBzYWZldH kgYW5kIGhh cyBhIHJpZ2 9yb3VzIHF1 YWxpdHkgbW FuYWdlbWVu dCBzeXN0ZW 0gaW4gcGxh Y2UgdG8gZW 5zdXJlIHRo ZWlyIHByb2 R1Y3RzIG1l ZXQgdGhlIG hpZ2hlc3Qg c3RhbmRhcm RzLjxicj43 LiBFbXBoYX NpcyBvbiBl ZHVjYXRpb2 4gYW5kIHRy YWluaW5nOi BUaGUgY29t cGFueSBoYX MgYSBzdHJv bmcgZW1waG FzaXMgb24g ZWR1Y2F0aW 9uIGFuZCB0 cmFpbmluZy wgb2ZmZXJp bmcgcHJvZ3 JhbXMgYW5k IHJlc291cm NlcyB0byBo ZWxwIGhlYW x0aGNhcmUg cHJvZmVzc2 lvbmFscyBz dGF5IHVwLX RvLWRhdGUg b24gdGhlIG xhdGVzdCB0 ZWNobmlxdW VzIGFuZCB0 ZWNobm9sb2 dpZXMgaW4g dmFzY3VsYX Igc3VyZ2Vy eS48YnI+OC 4gU3Ryb25n IHBhcnRuZX JzaGlwcyBh bmQgY29sbG Fib3JhdGlv bnM6IExlTW FpdHJlIFZh c2N1bGFyIH dvcmtzIGNs b3NlbHkgd2 l0aCBsZWFk aW5nIHZhc2 N1bGFyIHN1 cmdlb25zIG FuZCBoZWFs dGhjYXJlIG 9yZ2FuaXph dGlvbnMgdG 8gZGV2ZWxv cCBhbmQgcm VmaW5lIHRo ZWlyIHByb2 R1Y3RzLCBl bnN1cmluZy B0aGF0IHRo ZXkgbWVldC B0aGUgbmVl ZHMgb2YgcG F0aWVudHMg YW5kIHBoeX NpY2lhbnMu PGJyPjkuIE NvcnBvcmF0 ZSBzb2NpYW wgcmVzcG9u c2liaWxpdH k6IFRoZSBj b21wYW55IG hhcyBhIHN0 cm9uZyBjb2 1taXRtZW50 IHRvIGNvcn BvcmF0ZSBz b2NpYWwgcm VzcG9uc2li aWxpdHksIG ZvY3VzaW5n IG9uIHN1c3 RhaW5hYmls aXR5LCBldG hpY2FsIGJ1 c2luZXNzIH ByYWN0aWNl cywgYW5kIG dpdmluZyBi YWNrIHRvIH RoZSBjb21t dW5pdGllcy BpbiB3aGlj aCB0aGV5IG 9wZXJhdGUu PGJyPjEwLi BBd2FyZHMg YW5kIHJlY2 9nbml0aW9u OiBMZU1haX RyZSBWYXNj dWxhciBoYX MgcmVjZWl2 ZWQgbnVtZX JvdXMgYXdh cmRzIGFuZC ByZWNvZ25p dGlvbiBmb3 IgdGhlaXIg cHJvZHVjdH MsIGlubm92 YXRpb24sIG FuZCBidXNp bmVzcyBwcm FjdGljZXMs IGluY2x1ZG luZyBiZWlu ZyBuYW1lZC BvbmUgb2Yg Rm9yYmVzJy BCZXN0IFNt YWxsIENvbX BhbmllcyBp biBBbWVyaW NhLg==

TGVNYWl0cm UgVmFzY3Vs YXIgaXMgYS BtZWRpY2Fs IGRldmljZS Bjb21wYW55 IHRoYXQgc3 BlY2lhbGl6 ZXMgaW4gdG hlIGRldmVs b3BtZW50LC BtYW51ZmFj dHVyaW5nLC BhbmQgbWFy a2V0aW5nIG 9mIGlubm92 YXRpdmUgdm FzY3VsYXIg YW5kIGVuZG 92YXNjdWxh ciBwcm9kdW N0cyBmb3Ig dGhlIHRyZW F0bWVudCBv ZiBwZXJpcG hlcmFsIHZh c2N1bGFyIG Rpc2Vhc2Uu IFRoZWlyIG J1c2luZXNz IG1vZGVsIG ZvY3VzZXMg b24gZm91ci BrZXkgYXJl YXM6IHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCwg cHJvZHVjdG lvbiBhbmQg ZGlzdHJpYn V0aW9uLCBz YWxlcyBhbm QgbWFya2V0 aW5nLCBhbm QgY3VzdG9t ZXIgc2Vydm ljZS48YnI+ MS4gUmVzZW FyY2ggYW5k IERldmVsb3 BtZW50OiBM ZU1haXRyZS BWYXNjdWxh ciBpbnZlc3 RzIGhlYXZp bHkgaW4gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 IHRvIGNvbn RpbnVvdXNs eSBpbXByb3 ZlIHRoZWly IGV4aXN0aW 5nIHByb2R1 Y3RzIGFuZC BkZXZlbG9w IG5ldywgY3 V0dGluZy1l ZGdlIHRlY2 hub2xvZ2ll cy4gVGhlIG NvbXBhbnkg aGFzIGEgdG VhbSBvZiBz Y2llbnRpc3 RzLCBlbmdp bmVlcnMsIG FuZCBjbGlu aWNpYW5zIH dobyB3b3Jr IHRvZ2V0aG VyIHRvIGRl c2lnbiBhbm QgZGV2ZWxv cCBpbm5vdm F0aXZlIHNv bHV0aW9ucy Bmb3IgdmFz Y3VsYXIgc3 VyZ2VvbnMg YW5kIGludG VydmVudGlv bmFsaXN0cy 48YnI+Mi4g UHJvZHVjdG lvbiBhbmQg RGlzdHJpYn V0aW9uOiBM ZU1haXRyZS BWYXNjdWxh ciBtYW51Zm FjdHVyZXMg aXRzIHByb2 R1Y3RzIGlu LWhvdXNlLC BlbnN1cmlu ZyBzdHJpY3 QgcXVhbGl0 eSBjb250cm 9sIGFuZCB0 aW1lbHkgZG VsaXZlcnku IFRoZSBjb2 1wYW55IG9w ZXJhdGVzIG Rpc3RyaWJ1 dGlvbiBjZW 50ZXJzIGlu IHRoZSBVbm l0ZWQgU3Rh dGVzLCBFdX JvcGUsIGFu ZCBBc2lhIH RvIGVmZmlj aWVudGx5IH N1cHBseSBp dHMgcHJvZH VjdHMgdG8g aGVhbHRoY2 FyZSBwcm92 aWRlcnMgd2 9ybGR3aWRl Ljxicj4zLi BTYWxlcyBh bmQgTWFya2 V0aW5nOiBM ZU1haXRyZS BWYXNjdWxh ciBoYXMgYS BkaXJlY3Qg c2FsZXMgZm 9yY2UgdGhh dCBtYXJrZX RzIGl0cyBw cm9kdWN0cy B0byBob3Nw aXRhbHMsIG FtYnVsYXRv cnkgc3VyZ2 VyeSBjZW50 ZXJzLCBhbm QgaGVhbHRo Y2FyZSBmYW NpbGl0aWVz IGJvdGggZG 9tZXN0aWNh bGx5IGFuZC BpbnRlcm5h dGlvbmFsbH kuIFRoZSBj b21wYW55IG Fsc28gcGFy dG5lcnMgd2 l0aCBrZXkg ZGlzdHJpYn V0b3JzIGFu ZCBvdGhlci B0aGlyZC1w YXJ0eSBzYW xlcyBvcmdh bml6YXRpb2 5zIHRvIGV4 cGFuZCBpdH MgcmVhY2gu PGJyPjQuIE N1c3RvbWVy IFNlcnZpY2 U6IExlTWFp dHJlIFZhc2 N1bGFyIGlz IGNvbW1pdH RlZCB0byBw cm92aWRpbm cgZXhjZWxs ZW50IGN1c3 RvbWVyIHNl cnZpY2UsIG luY2x1ZGlu ZyBjbGluaW NhbCB0cmFp bmluZywgdG VjaG5pY2Fs IHN1cHBvcn QsIGFuZCBv bi1zaXRlIG Fzc2lzdGFu Y2UuIFRoZS Bjb21wYW55 IGFsc28gb2 ZmZXJzIGEg Y29tcHJlaG Vuc2l2ZSB3 YXJyYW50eS BhbmQgcmVw YWlyIHByb2 dyYW0gdG8g ZW5zdXJlIG N1c3RvbWVy IHNhdGlzZm FjdGlvbiBh bmQgbWluaW 1pemUgZG93 bnRpbWUuPG JyPk92ZXJh bGwsIExlTW FpdHJlIFZh c2N1bGFyJ3 MgYnVzaW5l c3MgbW9kZW wgZm9jdXNl cyBvbiBwcm 92aWRpbmcg aGlnaC1xdW FsaXR5LCBp bm5vdmF0aX ZlIHByb2R1 Y3RzIGFuZC Bjb21wcmVo ZW5zaXZlIH N1cHBvcnQg c2VydmljZX MgdG8gaGVh bHRoY2FyZS Bwcm92aWRl cnMsIGluIG 9yZGVyIHRv IGltcHJvdm UgcGF0aWVu dCBvdXRjb2 1lcyBhbmQg YmVjb21lIG EgdHJ1c3Rl ZCBwYXJ0bm VyIGluIHRo ZSB0cmVhdG 1lbnQgb2Yg cGVyaXBoZX JhbCB2YXNj dWxhciBkaX NlYXNlLg==

The sensitivity of LeMaitre Vascular’s earnings, cash flow, and valuation to changes in interest rates can be analyzed across several dimensions:
1. Earnings Impact: Higher interest rates can lead to increased borrowing costs for companies, potentially impacting LeMaitre Vascular if they rely on debt for financing operations, expansion, or R&D. Additionally, if interest rates rise, consumer spending may decrease, which can affect sales of their medical devices, especially in elective surgeries where patients might delay procedures due to costs.
2. Cash Flow Considerations: Cash flow sensitivity to interest rates primarily arises from changes in the cost of servicing debt. If LeMaitre has variable-rate debt, rising interest rates could increase interest payments, reducing net cash flow. Conversely, stable or declining interest rates could benefit the company’s cash flow by reducing debt service burdens.
3. Valuation Effects: Interest rates are a key component in discounting future cash flows during valuation. Higher interest rates typically lead to lower present values for future earnings, which can reduce the overall valuation of the company. Investors often require a higher return in a higher interest rate environment, which could further compress LeMaitre’s valuation multiples.
4. Market Competitiveness: In a rising interest rate environment, companies with lower debt levels and stronger balance sheets may have a competitive advantage. If LeMaitre Vascular manages its capital efficiently, it may be better positioned to withstand the pressures that accompany rising rates, such as increased competition from similarly situated firms facing higher capital costs.
5. Investment in Growth: Interest rate changes can affect LeMaitre’s decisions around capital expenditures and investment in new technologies or product lines. Higher rates might deter investment due to the increased cost of financing, potentially impacting long-term growth prospects.
In summary, LeMaitre Vascular’s sensitivity to interest rate changes is multifaceted, impacting its earnings through financing costs and consumer spending patterns, influencing cash flow primarily through debt servicing, and affecting valuation subjects to adjustment in discount rates applied by investors. Careful management of debt levels and capital allocation can help mitigate these sensitivities.

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvU1 l4dTMwTjM2 dTQ5WEFNd0 4xRlEud2Vi cCIgYWx0PS JMZU1haXRy ZSBWYXNjdW xhciIgdGl0 bGU9IkxlTW FpdHJlIFZh c2N1bGFyIi AgY2xhc3M9 ImltZy1mbH VpZCIgaGVp Z2h0PTkwIH dpZHRoPTkw IGxvYWRpbm c9J2xhenkn IHN0eWxlPS dib3JkZXIt cmFkaXVzOi A2cHg7Jz4K CiAgICAgIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nZmxleD ogMTsgdGV4 dC1hbGlnbj ogY2VudGVy OyBtYXJnaW 4tbGVmdDog NXB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdmb250 LXNpemU6ID I2cHg7IGNv bG9yOiAjMz MzOyBtYXJn aW4tYm90dG 9tOiAxNXB4 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICDwn5OIIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IExlTWFpdH JlIFZhc2N1 bGFyPwogIC AgICAgICAg ICAgICAgIC AgICAgICA8 L3A+CgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 YSBocmVmPS dpbmRleC5w aHA/cGFnZT 1zaWdudXAn IHN0eWxlPS cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JhY2tncm91 bmQtY29sb3 I6ICMwMDdC RkY7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBjb2xvcj ogI2ZmZjsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHBh ZGRpbmc6ID EwcHggMjBw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJvcmRlci 1yYWRpdXM6 IDVweDsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogbm 9uZTsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGZvbnQt d2VpZ2h0Oi Bib2xkOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgbWFy Z2luLXJpZ2 h0OiAxMHB4 OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dHJhbnNpdG lvbjogYmFj a2dyb3VuZC 1jb2xvciAw LjNzIGVhc2 U7JwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Agb25tb3Vz ZW92ZXI9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A1NmIzIicK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIG9u bW91c2VvdX Q9J3RoaXMu c3R5bGUuYm Fja2dyb3Vu ZENvbG9yPS IjMDA3QkZG Iic+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBTaWduIH VwIGZvciBm cmVlCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv YT4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxz cGFuIHN0eW xlPSdtYXJn aW46IDAgOH B4OyBjb2xv cjogIzU1NT snPm9yPC9z cGFuPgoKIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naW5kZXgu cGhwP3BhZ2 U9bG9naW4n IHN0eWxlPS cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG NvbG9yOiAj MDA3QkZGOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdG V4dC1kZWNv cmF0aW9uOi B1bmRlcmxp bmU7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBmb250LX dlaWdodDog NTAwOyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBsb2 cgaW4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgoKCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdtYXJnaW 4tdG9wOiAx NXB4OyBmb2 50LXNpemU6 IDEzcHg7IG ZvbnQtd2Vp Z2h0OiBib2 xkOyBjb2xv cjogI2QzMm YyZjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAg8J+G kyBEaXNjb3 ZlciA8aT4i VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr cyI8L2k+IO KAlCBmcmVl IGVCb29rIQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L3A+Cg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8IS0tCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxkaXYgc3 R5bGU9J21h cmdpbi10b3 A6IDEycHg7 IGZvbnQtc2 l6ZTogMTNw eDsgY29sb3 I6ICM0NDQ7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IFNpZ24gdX Agbm93IGFu ZCBnZXQgb3 VyIGZyZWUg ZUJvb2sgCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8Yj 5UaGUgQ2hl Y2tsaXN0IF ZhbHVlIElu dmVzdG9yIO KAlCBBIFNt YXJ0ZXIgV2 F5IHRvIFBp Y2sgU3RvY2 tzPC9iPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID whLS0KICAg ICAgICAgIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nbWFyZ2 luLXRvcDog MTZweDsgZm 9udC1zaXpl OiAxNHB4Oy Bjb2xvcjog IzQ0NDsgZm 9udC1mYW1p bHk6IC1hcH BsZS1zeXN0 ZW0sIEJsaW 5rTWFjU3lz dGVtRm9udC wgU2Vnb2Ug VUksIFJvYm 90bywgSGVs dmV0aWNhIE 5ldWUsIHNh bnMtc2VyaW Y7IGxpbmUt aGVpZ2h0Oi AxLjY7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIEhh dmUgeW91IG hlYXJkIGFi b3V0IG91ci BzaG9ydCA8 c3Ryb25nIH N0eWxlPSdm b250LXdlaW dodDogNjAw Oyc+RGFpbH kgVmlkZW8g TmV3c2xldH Rlcjwvc3Ry b25nPj8KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxhIG hyZWY9J2h0 dHBzOi8vd3 d3Lmluc2ln aHRmdWx2YW x1ZS5jb20v bmV3c2xldH Rlci5waHAn IHRhcmdldD 0nX2JsYW5r JyBzdHlsZT 0nY29sb3I6 ICMwMDdCRk Y7IHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsgZm9udC 13ZWlnaHQ6 IDUwMDsgbW FyZ2luLWxl ZnQ6IDZweD snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIEZp bmQgb3V0IG 1vcmUKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIC0tPgog ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAKIC AgICAgICAK ICAgICAgIC A8c3BhbiBj bGFzcz0nYm x1cnJlZC10 ZXh0Jz4KIC AgICAgICAg ICAgTVNrZ1 ZHaGxJRSB4 bFRXRnBkSE psIElGWmhj Mk4xYkcgRn lJR052YlhC aCBibmtnZD JGeklHIFp2 ZFc1a1pXUW cgYVc0Z01U azRNeSBCaW VTQkhaVzl5 IFoyVWdUR1 ZOWVcgbDBj bVVzSUdFZy BkbUZ6WTNW c1lYIElnYz NWeVoyVnYg Ymk0Z1BHSn lQaiBJcElG Um9aU0JqIG IyMXdZVzU1 SUggTndaV0 5wWVd4cCBl bVZ6SUdsdU lHIFJsZG1W c2IzQnAgYm 1jZ1lXNWtJ RyAxaGNtdG xkR2x1IFp5 QnRaV1JwWT IgRnNJR1Js ZG1saiBaWE 1nWm05eUlI IFJvWlNCMG NtVmggZEcx bGJuUWdiMi BZZ2NHVnlh WEJvIFpYSm hiQ0IyWVgg TmpkV3hoY2 lCayBhWE5s WVhObExDIE IzYUdsamFD QmggWm1abF kzUnpJSCBS b1pTQmliRz l2IFpDQjJa WE56WlcgeH pJRzkxZEhO cCBaR1VnYj JZZ2RHIGhs SUdobFlYSj AgSUdGdVpD QmljbSBGcG JpNGdQR0p5 IFBqTXBJRW wwY3kgQm9a V0ZrY1hWaC BjblJsY25N Z1lYIEpsSU d4dlkyRjAg WldRZ2FXNG dRbiBWeWJH bHVaM1J2IG Jpd2dUV0Z6 YzIgRmphSF Z6WlhSMCBj eXdnWVc1a0 lHIGwwSUdo aGN5QmggSU dkc2IySmhi QyBCd2NtVn paVzVqIFpT QjNhWFJvSU cgOXdaWEpo ZEdsdiBibk 1nYVc0Z1JY IFZ5YjNCbE xDQkIgYzJs aExDQmhibS BRZ1RHRjBh VzRnIFFXMW xjbWxqWVMg NGdQR0p5UG pRcCBJRXhs VFdGcGRIIE psSUZaaGMy TjEgYkdGeU lIZGhjeSBC MGFHVWdabW x5IGMzUWdZ Mjl0Y0cgRn VlU0IwYnlC dCBZWEpyWl hRZ2RHIGhs SUhWeVpYUm wgY21Gc0lH TmhkRyBobG RHVnlMQ0Ix IGMyVmtJSF J2SUggSmxi VzkyWlNCci BhV1J1Wlhr Z2MzIFJ2Ym 1WeklIUm8g Y205MVoyZ2 dZUyBCd1lY UnBaVzUwID RvQ1pjeUIx Y20gbHVZWE o1SUhSeSBZ V04wTGlBOF luIEkrTlNr Z1NYUWcgZD JGeklHRnNj MiA4Z2IyNW xJRzltIElI Um9aU0JtYV ggSnpkQ0Jq YjIxdyBZVz VwWlhNZ2RH IDhnYVc1MG NtOWsgZFdO bElIUm9aUy BCamIyNWpa WEIwIElHOW 1JR1Z1Wkcg OTJZWE5qZF d4aCBjaUJ6 ZFhKblpYIE o1TENCM2FH bGogYUNCMW RHbHNhWCBw bGN5QnRhVz VwIGJXRnNi SGtnYVcgNT JZWE5wZG1V ZyBkR1ZqYU c1cGNYIFZs Y3lCMGJ5Qj AgY21WaGRD QjJZWCBOam RXeGhjaUJr IGFYTmxZWE 5sY3kgNGdQ R0p5UGpZcC BJRWx1SURJ d01UIEFzSU V4bFRXRnAg ZEhKbElGWm hjMiBOMWJH RnlJR0ZqIG NYVnBjbVZr SUggUm9aU0 J6ZFhKbiBh V05oYkNCcG JuIE4wY25W dFpXNTAgY3 lCa2FYWnBj MiBsdmJpQn ZaaUJCIGJt ZHBiM1JsWT IgZ2dVR2ho Y20xaCBZMl YxZEdsallX IHh6TENCSm JtTXUgTENC bGVIQmhibS BScGJtY2dh WFJ6IElIQn liMlIxWTMg UWdjRzl5ZE dadiBiR2x2 TGlBOFluIE krTnlrZ1ZH aGwgSUdOdm JYQmhibiBr Z2FHRnpJSE psIFkyVnBk bVZrSUcgNT FiV1Z5YjNW eiBJR0YzWV hKa2N5IEJo Ym1RZ2NtVm ogYjJkdWFY UnBiMiA0Z1 ptOXlJR2ww IGN5QnBibT V2ZG0gRjBh WFpsSUcxbC BaR2xqWVd3 Z1pHIFYyYV dObGN5d2cg YVc1amJIVm thVyA1bklI Um9aU0JHIG NtOXpkQ0Ft SUYgTjFiR3 hwZG1GdSBJ RWR5YjNkMG FDIEJGZUdO bGJHeGwgYm 1ObElFeGxZ VyBSbGNuTm 9hWEFnIFFY ZGhjbVFnYV cgNGdNakF4 T1M0ZyBQR0 p5UGpncElG IFJvWlNCdV lXMWwgSUV4 bFRXRnBkSC BKbElHbHpJ R1JsIGNtbD JaV1FnWm4g SnZiU0IwYU dVZyBSbkps Ym1Ob0lIIF JsY20wZ2JH VWcgYldIRH JuUnlaUyB3 Z2QyaHBZMm dnIGJXVmhi bk1nZEcgaG xJRzFoYzNS bCBjaUJ2Y2 lCMGFHIFVn ZEdWaFkyaG wgY2k0Z1ZH aHBjeSBCeV pXWnNaV04w IGN5QjBhR1 VnWTIgOXRj R0Z1ZWVLQS BtWE1nWTI5 dGJXIGwwYl dWdWRDQjAg YnlCamIyNX pkRyBGdWRH eDVJR3hsIF lYSnVhVzVu SUcgRnVaQ0 JwYlhCeSBi M1pwYm1jZ2 FXIDRnZEdo bElHWnAgWl d4a0lHOW1J SCBaaGMyTj FiR0Z5IElI TjFjbWRsY2 4ga3VJRHhp Y2o0NSBLU0 JNWlUxaGFY IFJ5WlNCV1 lYTmogZFd4 aGNpQm9ZWC BNZ1lTQnpk SEp2IGJtY2 dabTlqZFgg TWdiMjRnYz I5aiBhV0Zz SUhKbGMzIE J2Ym5OcFlt bHMgYVhSNU lHRnVaQyBC amIyNTBjbW xpIGRYUmxj eUIwYnkgQj JZWEpwYjNW eiBJR05vWV hKcGRHIEZp YkdVZ1kyRj EgYzJWekxD QnBibSBOc2 RXUnBibWNn IGMzVndjRz l5ZEcgbHVa eUJqYUdscy BaSEpsYnVL QW1YIE1nYU dWaGJIUm8g WTJGeVpTQm hibSBRZ2NI SnZkbWxrIG FXNW5JRzFs WkcgbGpZV3 dnYzNWdyBj R3hwWlhNZ2 RHIDhnZFc1 a1pYSnogWl hKMlpXUWdj bSBWbmFXOX VjeTRnIFBH SnlQakV3S1 MgQkJjeUJ2 WmlBeSBNRE l4TENCMGFH IFVnWTI5dG NHRnUgZVNC b1lYTWdiMy BabGNpQXpO U0J3IFlYUm xiblJ6SUcg RnVaQ0JqYj I1MCBhVzUx WlhNZ2RHID hnYVc1MlpY TjAgSUdsdU lISmxjMiBW aGNtTm9JR0 Z1IFpDQmta WFpsYkcgOX diV1Z1ZENC MCBieUJpY2 1sdVp5IEJw Ym01dmRtRj AgYVhabElI TnZiSCBWMG FXOXVjeUIw IGJ5QjBhR1 VnYlcgRnlh MlYwSUdadi BjaUIwYUdV Z2RIIEpsWV hSdFpXNTAg SUc5bUlIWm hjMiBOMWJH RnlJR1JwIG MyVmhjMlZ6 TGcgPT0KIC AgICAgICA8 L3NwYW4+Ci AgICAgICAg CiAgICAgIC Ag
See Company Q&A